Safeguard Scientifics, Inc. SFES
0.41
0.00
0.00%
as of 25 Sep
- Market cap
- $7.5M
- P/E
- 0.4×
Follow SFES
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(25.78%) | 16.14% | 106.97% | 237.38% | |
| (23.47%) | 14.48% | 101.59% | 214.23% | ||
ROIC |
(48.87%) | (50.98%) | (98.58%) | (84.13%) | |
Return on Tangible Assets |
(41.12%) | 20.79% | 74.41% | 449.49% | |
Free Cash Flow per Share |
(0.11) | (0.11) | (0.10) | (0.08) | |
Free Cash Flow |
(1.91) | (1.77) | (1.65) | (1.26) | |
Piotroski F-Score |
3.00 | 3.00 | 3.00 | 3.00 | |
| Other line items | |||||
Cash ROIC |
(9.11%) | (8.63%) | (2.81%) | (11.42%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.55 | (1.03) | (0.08) | (0.06) | |
Depreciation/Fixed assets |
— | 0.00 | — | — | |
Capex/Depreciation |
— | 0.00 | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.11) | (0.11) | (0.10) | (0.08) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates